Sustained efficacy up to 4·5 years of a bivalent L1...

Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Diane M Harper, Eduardo L Franco, Cosette M Wheeler, Anna-Barbara Moscicki, Barbara Romanowski, Cecilia M Roteli-Martins, David Jenkins, Anne Schuind, Sue Ann Costa Clemens, Gary Dubin
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
367
Year:
2006
Language:
english
DOI:
10.1016/s0140-6736(06)68439-0
File:
PDF, 134 KB
english, 2006
Conversion to is in progress
Conversion to is failed